Correlation Between Quantitative Analysis of Coronary MRA and FFR

NCT ID: NCT03117218

Last Updated: 2017-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

89 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-07-01

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate whether quantitative analysis of coronary MR angiogram would improve the detection of functionally-significant coronary artery stenosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coronary MR angiography is performed with a 3.0-T imager with 32-channel coils. Qunatitative analysis of coronary MR angiogram is evaluated on the basis of the signal intensity (SI) profile along the vessel. Quantitative analysis of coronary MR angiogram (QCMRA) is calculated as \[1 - (SImin/SIref)\] x 100, where SImin is minimal SI and SIref is corresponding reference SI. Diagnostic performance of quantitative analysis of coronary MR angiogram for predicting functional significant coronary stenosis was evaluated by using fractional flow reserve (FFR) as the reference standard.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Magnetic Resonance Angiography Fractional Flow Reserve

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coronary MR angiography

Quantitative analysis of coronary MR angiogram

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* 1 or more coronary stenoses in the major coronary artery with a vessel diameter ≥ 2mm on coronary MR angiogram
* Patient who were planned to undergo invasive coronary angiography and fractional flow reserve

Exclusion Criteria

* clinically unstable patient
* a history of coronary revascularization
* infiltrative cardiomyopathy, hypertropic cardiomyopathy, myocarditis
* contraindication to use of adenosine
* complete occlusion of target lesion
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Bundang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yeonyee E Yoon, MD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Bundang Hopsital

Seongnam-si, Gyeonggi-do, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yeonyee E Yoon, MD

Role: CONTACT

+82-31-787-7072

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yeonyee E Yoon, MD

Role: primary

+82-31-787-7072

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B-1408/262-006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Korea Atherosclerosis Study-3
NCT01168362 COMPLETED
The FAVOR II China Study
NCT03191708 COMPLETED
Study of Blood Flow in Heart Muscle
NCT00001631 COMPLETED PHASE2